Literature DB >> 34556863

Structures of the human cholecystokinin receptors bound to agonists and antagonists.

Xuefeng Zhang1,2, Chenglin He3, Mu Wang1,2,4, Qingtong Zhou5,6, Dehua Yang1,2,7, Ya Zhu1, Wenbo Feng3, Hui Zhang1,2, Antao Dai7, Xiaojing Chu1, Jia Wang7, Zhenlin Yang1, Yi Jiang1, Ulrich Sensfuss8, Qiuxiang Tan1, Shuo Han1, Steffen Reedtz-Runge8, H Eric Xu1,2, Suwen Zhao9,10, Ming-Wei Wang11,12,13,14,15,16, Beili Wu17,18,19,20, Qiang Zhao21,22,23,24.   

Abstract

Cholecystokinin receptors, CCKAR and CCKBR, are important neurointestinal peptide hormone receptors and play a vital role in food intake and appetite regulation. Here, we report three crystal structures of the human CCKAR in complex with different ligands, including one peptide agonist and two small-molecule antagonists, as well as two cryo-electron microscopy structures of CCKBR-gastrin in complex with Gi2 and Gq, respectively. These structures reveal the recognition pattern of different ligand types and the molecular basis of peptide selectivity in the cholecystokinin receptor family. By comparing receptor structures in different conformational states, a stepwise activation process of cholecystokinin receptors is proposed. Combined with pharmacological data, our results provide atomic details for differential ligand recognition and receptor activation mechanisms. These insights will facilitate the discovery of potential therapeutics targeting cholecystokinin receptors.
© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34556863     DOI: 10.1038/s41589-021-00866-8

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  54 in total

Review 1.  Cholecystokinin: proofs and prospects for involvement in control of food intake and body weight.

Authors:  R C Ritter; M Covasa; C A Matson
Journal:  Neuropeptides       Date:  1999-10       Impact factor: 3.286

Review 2.  Insights into the binding and activation sites of the receptors for cholecystokinin and gastrin.

Authors:  Magali Foucaud; Elodie Archer-Lahlou; Esther Marco; Irina G Tikhonova; Bernard Maigret; Chantal Escrieut; Ingrid Langer; Daniel Fourmy
Journal:  Regul Pept       Date:  2007-09-25

Review 3.  Cholecystokinin and gastrin receptors.

Authors:  Marlène Dufresne; Catherine Seva; Daniel Fourmy
Journal:  Physiol Rev       Date:  2006-07       Impact factor: 37.312

Review 4.  Gastrointestinal hormones and their targets.

Authors:  Jens F Rehfeld
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 5.  Phylogeny of the cholecystokinin/gastrin family.

Authors:  A H Johnsen
Journal:  Front Neuroendocrinol       Date:  1998-04       Impact factor: 8.606

6.  Cloning and sequence analysis of a cDNA encoding rat preprocholecystokinin.

Authors:  R J Deschenes; L J Lorenz; R S Haun; B A Roos; K J Collier; J E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

7.  Gastrin induces IP3 formation through phospholipase C gamma 1 and pp60c-src kinase.

Authors:  R R Yassin; J T Abrams
Journal:  Peptides       Date:  1998       Impact factor: 3.750

Review 8.  The biology of cholecystokinin and gastrin peptides.

Authors:  Jens F Rehfeld; Lennart Friis-Hansen; Jens P Goetze; Thomas V O Hansen
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

9.  CCK and gastrin inhibit adenylate cyclase activity through a pertussis toxin-sensitive mechanism in the tumoral rat pancreatic acinar cell line AR 4-2J.

Authors:  J L Scemama; P Robberecht; M Waelbroeck; P De Neef; L Pradayrol; N Vaysse; J Christophe
Journal:  FEBS Lett       Date:  1988-12-19       Impact factor: 4.124

Review 10.  Cholecystokinin receptors.

Authors:  S A Wank
Journal:  Am J Physiol       Date:  1995-11
View more
  6 in total

Review 1.  AlphaFold2 versus experimental structures: evaluation on G protein-coupled receptors.

Authors:  Xin-Heng He; Chong-Zhao You; Hua-Liang Jiang; Yi Jiang; H Eric Xu; Xi Cheng
Journal:  Acta Pharmacol Sin       Date:  2022-07-01       Impact factor: 6.150

2.  Transmembrane Domain 3 Is a Transplantable Pharmacophore in the Photodynamic Activation of Cholecystokinin 1 Receptor.

Authors:  Yuan Li; Zong Jie Cui
Journal:  ACS Pharmacol Transl Sci       Date:  2022-07-08

3.  Structural insights into ligand binding and activation of the human thyrotropin-releasing hormone receptor.

Authors:  Youwei Xu; Hongmin Cai; Chongzhao You; Xinheng He; Qingning Yuan; Hualiang Jiang; Xi Cheng; Yi Jiang; H Eric Xu
Journal:  Cell Res       Date:  2022-04-01       Impact factor: 46.297

4.  Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2.

Authors:  Youwen Zhuang; Lei Wang; Jia Guo; Dapeng Sun; Yue Wang; Weiyi Liu; H Eric Xu; Cheng Zhang
Journal:  Nat Commun       Date:  2022-02-25       Impact factor: 14.919

5.  Neural circuit mechanisms of the cholecystokinin (CCK) neuropeptide system in addiction.

Authors:  Yihe Ma; William J Giardino
Journal:  Addict Neurosci       Date:  2022-06-17

Review 6.  Novel Molecular Targets of Antidepressants.

Authors:  Małgorzata Jarończyk; Jarosław Walory
Journal:  Molecules       Date:  2022-01-14       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.